Skip to main content
Equibles
BSEM logo

BSEM · BioStem Technologies, Inc. · Metrics

Track BSEM — free

Use BSEM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BSEM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.18 -0.04 (-0.83%) At close · Sep 10
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Accordingly, substantial doubt exists about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements.”
View the 10-Q filed Aug 12, 2026
Market Cap
$76.40M
Shares
17.85M

BSEM metrics

42 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.18
Market cap
$76.40M

Price action

20 metrics
Price change (1W)
+18.9%
Price change (30D)
+16.6%
Price change (3M)
+22.7%
Price change (6M)
-18.5%
Price change (YTD)
+10.5%
Price change (1Y)
-28.2%
Trailing year
Price change (5Y)
+321.0%
52-week high
$8.20
52-week low
$3.00
Change from 52-week high
-48.7%
Change from 52-week low
+40.3%
Annualized volatility
114.6%
Annualized volatility (3M)
109.2%
Beta
1.4
RSI (14D)
60.9
Price vs SMA 50
+17.1%
Price vs SMA 200
-5.5%
Avg volume (3M)
80,645
Relative volume
1.5
Average dollar volume
$293,671

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
17.85M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.8
reciprocal yield 36.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.33

Growth

11 metrics
Revenue growth YoY
-27.9%
Year over year
Net income growth YoY
-84,631.8%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-26.0%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
—
Debt / equity
0.0
Current ratio
1.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$6.96M
Latest balance sheet
Cash & equivalents
$6.96M
Total assets
$48.82M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1658678 CUSIP 090684200 Visit website Investor relations